Marksans Pharma informs about press release

03 Oct 2023 Evaluate
Marksans Pharma has informed that it has received final approval from US FDA for its Abbreviated New Drug Application (ANDA) for Esomeprazole Magnesium delayed-release capsule USP, 20 mg (OTC).

The above information is a part of company’s filings submitted to BSE.

Marksans Pharma Share Price

173.45 1.20 (0.70%)
19-Jan-2026 15:56 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1673.55
Dr. Reddys Lab 1166.45
Cipla 1386.00
Zydus Lifesciences 879.00
Lupin 2178.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×